Evidence map›Paper›PMID 38551913›Full record

SynthesisPloS one2024

Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic review.

Agniete Kampaite, Rebecka Gustafsson, Elizabeth N York, Peter Foley, Niall J J MacDougall, Mark E Bastin, Siddharthan Chandran, Adam D Waldman, Rozanna Meijboom

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Network Localization of Fatigue in Multiple Sclerosis.Annals of clinical and translational neurology · 2026
    Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Baseline Expanded Disability Status Scale Score and CD8Journal of inflammation research · 2025
    Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Agniete KampaiteCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-7266-002X
Rebecka GustafssonCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Elizabeth N YorkCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-4310-8607
Peter FoleyCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Niall J J MacDougallAnne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0002-4195-5538
Mark E BastinCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Siddharthan ChandranCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Adam D WaldmanCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Rozanna MeijboomCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.ORCID 0000-0003-3346-260X
University of Edinburgh · GBMRC Centre for Regenerative Medicine · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple Sclerosis (MS) is an autoimmune disease affecting the central nervous system, characterised by neuroinflammation and neurodegeneration. Fatigue and depression are common, debilitating, and intertwined symptoms in people with relapsing-remitting MS (pwRRMS). An increased understanding of brain changes and mechanisms underlying fatigue and depression in RRMS could lead to more effective interventions and enhancement of quality of life. To elucidate the relationship between depression and fatigue and brain connectivity in pwRRMS we conducted a systematic review. Searched databases were PubMed, Web-of-Science and Scopus. Inclusion criteria were: studied participants with RRMS (n ≥ 20; ≥ 18 years old) and differentiated between MS subtypes; published between 2001-01-01 and 2023-01-18; used fatigue and depression assessments validated for MS; included brain structural, functional magnetic resonance imaging (fMRI) or diffusion MRI (dMRI). Sixty studies met the criteria: 18 dMRI (15 fatigue, 5 depression) and 22 fMRI (20 fatigue, 5 depression) studies. The literature was heterogeneous; half of studies reported no correlation between brain connectivity measures and fatigue or depression. Positive findings showed that abnormal cortico-limbic structural and functional connectivity was associated with depression. Fatigue was linked to connectivity measures in cortico-thalamic-basal-ganglial networks. Additionally, both depression and fatigue were related to altered cingulum structural connectivity, and functional connectivity involving thalamus, cerebellum, frontal lobe, ventral tegmental area, striatum, default mode and attention networks, and supramarginal, precentral, and postcentral gyri. Qualitative analysis suggests structural and functional connectivity changes, possibly due to axonal and/or myelin loss, in the cortico-thalamic-basal-ganglial and cortico-limbic network may underlie fatigue and depression in pwRRMS, respectively, but the overall results were inconclusive, possibly explained by heterogeneity and limited number of studies. This highlights the need for further studies including advanced MRI to detect more subtle brain changes in association with depression and fatigue. Future studies using optimised imaging protocols and validated depression and fatigue measures are required to clarify the substrates underlying these symptoms in pwRRMS.

Indexed as

Multiple Sclerosis, Relapsing-RemittingAdultBrainDepressionFatigueHumansMagnetic Resonance ImagingMultiple SclerosisQuality of Life

Identifiers

PMID38551913
PMCPMC10980255
OpenAlexW4393305714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.